197 related articles for article (PubMed ID: 35801303)
1. Directional atherectomy and drug-coated balloon angioplasty vs. bare nitinol stent angioplasty for femoropopliteal artery lesions.
Wei L; Guo J; Guo L; Qi L; Cui S; Tong Z; Hou P; Gu Y
Vasa; 2022 Sep; 51(5):275-281. PubMed ID: 35801303
[No Abstract] [Full Text] [Related]
2. Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans.
Cai Z; Guo L; Qi L; Cui S; Tong Z; Guo J; Wang Z; Gu Y
Ann Vasc Surg; 2020 Apr; 64():181-187. PubMed ID: 31449956
[TBL] [Abstract][Full Text] [Related]
3. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
Rodoplu O; Oztas DM; Meric M; Beyaz MO; Ulukan MO; Yildiz CE; Unal O; Ugurlucan M
Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions in intermittent claudication: A network meta-analysis of randomized controlled trials.
Zhou Y; Wang J; He H; Li Q; Li M; Li X; Shu C
Int J Cardiol; 2021 Nov; 343():122-130. PubMed ID: 34461162
[TBL] [Abstract][Full Text] [Related]
6. Mid-term Efficacy and Safety of Drug-coated Balloon versus Nitinol Bare Metal Stent for Primary Lesions in Femoropopliteal Artery Disease.
Ma H; Zhang X; Li J; Li Q; Li W; Jiao Y; Jiang J; He C; He Z; Li W; Zhang T; Zhang X
Ann Vasc Surg; 2022 Apr; 81():316-323. PubMed ID: 34762999
[TBL] [Abstract][Full Text] [Related]
7. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
Stavroulakis K; Schwindt A; Torsello G; Beropoulis E; Stachmann A; Hericks C; Bollenberg L; Bisdas T
J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
[TBL] [Abstract][Full Text] [Related]
8. Drug-Coated Balloon versus Bare Nitinol Stent in Femoropopliteal Artery: 12 Months Outcome from a Single Center in China.
Zhao H; Ma B; Chen J; Zheng L; Sun CR; Sun MS; Zhang JB; Fan XQ; Liu P; Ye ZD
Ann Vasc Surg; 2021 Jul; 74():367-381. PubMed ID: 33556529
[TBL] [Abstract][Full Text] [Related]
9. Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
Rocha-Singh KJ; Sachar R; DeRubertis BG; Nolte-Ernsting CCA; Winscott JG; Krishnan P; Scott EC; Garcia LA; Baeriswyl JL; Ansel G; Rosenfield K; Zeller T;
Catheter Cardiovasc Interv; 2021 Sep; 98(3):549-558. PubMed ID: 34080792
[TBL] [Abstract][Full Text] [Related]
10. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
Zeller T; Langhoff R; Rocha-Singh KJ; Jaff MR; Blessing E; Amann-Vesti B; Krzanowski M; Peeters P; Scheinert D; Torsello G; Sixt S; Tepe G;
Circ Cardiovasc Interv; 2017 Sep; 10(9):e004848. PubMed ID: 28916599
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion.
Yang L; Quan J; Dong J; Ding N; Han Y; Cong L; Lin Y; Liu J
Sci Rep; 2024 Jan; 14(1):63. PubMed ID: 38167567
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Stented vs Nonstented Femoropopliteal Lesions Treated With Drug-Coated Balloon Angioplasty.
Giannopoulos S; Strobel A; Rudofker E; Kovach C; Kokkosis AA; Armstrong EJ
J Endovasc Ther; 2023 Apr; 30(2):194-203. PubMed ID: 35179065
[TBL] [Abstract][Full Text] [Related]
13. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
[TBL] [Abstract][Full Text] [Related]
14. One-Year Clinical Outcome and Risk Factor Analysis of Directional Atherectomy Followed With Drug-Coated Balloon for Femoropopliteal Artery Disease.
Feng Z; Yang S; Sang H; Xue G; Ni Q; Zhang L; Zhang W; Fang X; Ye M
J Endovasc Ther; 2021 Dec; 28(6):927-937. PubMed ID: 34251279
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Imran HM; Hyder ON; Soukas PA
Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
[TBL] [Abstract][Full Text] [Related]
16. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
[TBL] [Abstract][Full Text] [Related]
17. Rotational atherectomy with adjunctive balloon angioplasty in calcified chronic total occlusions of superficial femoral artery.
Engin AY; Saydam O
Vascular; 2021 Oct; 29(5):682-692. PubMed ID: 33167805
[TBL] [Abstract][Full Text] [Related]
18. Comparative Outcomes of Supera Interwoven Nitinol vs Bare Nitinol Stents for the Treatment of Femoropopliteal Disease: Insights From the XLPAD Registry.
Armstrong EJ; Jeon-Slaughter H; Kahlon RS; Niazi KA; Shammas NW; Banerjee S
J Endovasc Ther; 2020 Feb; 27(1):60-65. PubMed ID: 31686573
[No Abstract] [Full Text] [Related]
19. Early outcomes of novel Temren atherectomy device combined with drug-coated balloon angioplasty for treatment of femoropopliteal lesions.
Yiğit G
Vascular; 2022 Aug; 30(4):739-748. PubMed ID: 34180304
[TBL] [Abstract][Full Text] [Related]
20. Primary Drug-Coated Balloon Versus Drug-Eluting Stent for Native Atherosclerotic Femoropopliteal Lesions: A Systematic Review and Meta-Analysis.
Zenunaj G; Traina L; Acciarri P; Mario Cosacco A; Alesiani F; Baldazzi G; Gasbarro V
Ann Vasc Surg; 2023 May; 92():294-303. PubMed ID: 36746268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
